Navigation Links
AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver
Date:4/22/2009

QUEBEC CITY, April 22 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer. The poster was presented at the American Association for Cancer Research (AACR) Annual Meeting in Denver, Colorado.

The poster (#5567) entitled, "Phase I dose-escalation, safety, and pharmacokinetic study on weekly oral AEZS-112, a small molecule anti-cancer agent in patients with advanced cancer and lymphoma", D.W. Northfelt, reviewed results of this Phase I study designed to evaluate the safety, tolerability and pharmacokinetics of ascending doses of AEZS-112 in patients with the above-mentioned forms of cancer.

Results

In part I, 22 patients (12 men/10 women) were studied on 7 dose levels ranging from 13 to 800 mg/week. In all, 62 treatment cycles were administered. In part II, 22 patients (12 men/10 women) were studied on 5-dose levels ranging from 120 to 600 (=200x3) mg/week. As of April 1, 2009, 62 treatment cycles were administered (mean 3.2/patient); treatment was ongoing in 8 patients. Stable disease (SD) for more than 12 weeks was observed in 16 patients; 4 more patients were ongoing at less than 12 weeks. Prolonged courses of SD ranging from 20 to 39+ weeks were observed in 9 patients with the following primary cancer types: trachea (39+), tongue (30+), thyroid (29+), prostate and melanoma (28), non-small cell lung cancer (26+), pancreas and 2x colorectal (20).

Except for one patient with a background of gastrointestinal problems (GI) who had dose-limiting GI reactions a
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  NASA astronaut Kjell Lindgren , who ... his first mission to the International Space Station , ... 9 a.m. EDT Tuesday, July 7. Lindgren will ... Russia . The interviews will be preceded ... his mission training. To schedule an interview, media ...
(Date:6/30/2015)... Church, VA (PRWEB) , ... June 30, 2015 ... ... and strategy services to the federal government, announced in a paper published this ... scientists uncovered a potential problem with the diagnostic techniques currently used to detect ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/29/2015)... ... June 30, 2015 , ... This cutting edge standard making is a madatory ... distinct peaks, the WAV-8 is the world’s first cuvette-shaped, solid-state filter that lets metrologists ... NIR range. Previous spectrophotometer calibration standards, such as those made from didymium glass were ...
Breaking Biology Technology:NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 2Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 3Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 4RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3
... , , AUSTIN, Texas, Jan. 7 Bender Consulting, ... key trends and merger and acquisition (M&A) related activity that ... sector for 2010. Bender Consulting combines proven industry experts and ... Tech, Energy and Bio Tech clients. The talent at Bender ...
... , FT. LAUDERDALE, Fla. , Jan. 15 ... Fund to provide further investment for the company,s growth in the ... is how CEO Chris Hamilton views this decision. "Funding ... and ultimately reducing Carbon Emissions feature so highly on the agenda ...
... , DURHAM, N.C. , Jan. 14 ... announced Wednesday the award of $44 million in ... (NAABB), a consortium including Palmer Labs, LLC , of Durham, ... Palmer Labs of its patent-pending algae technology addressing both energy and nutritional ...
Cached Biology Technology:Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 2Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 3InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market 2Palmer Labs Awarded U.S. Department of Energy Funding for Algae Biofuel Research 2Palmer Labs Awarded U.S. Department of Energy Funding for Algae Biofuel Research 3Palmer Labs Awarded U.S. Department of Energy Funding for Algae Biofuel Research 4
(Date:6/16/2015)... 2015 Fingerprint Cards has received an ... the company,s portfolio from one of its module partners in ... take place during the third quarter 2015. The sensors will ... . Jörgen Lantto, CEO of FPC, comments: " ... growing interest from smartphone OEMs in integrating touch fingerprint sensors ...
(Date:6/15/2015)... , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces that its ... showcased to media at Digital Experience! @ NYC June 18th. ... showcase of the latest innovation in technology to over 300 ... be held at the Metropolitan Pavilion in New ...
(Date:6/9/2015)... June 9, 2015   MedNet Solutions , an ... spectrum of clinical research, will be providing demonstrations of ... at the 2015 Drug Information Association (DIA) Annual Meeting ... 15-17.  These presentations will include previews of many exciting ... the upcoming iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
... is no longer necessary for growing potatoes, at least ... is undertaking a research project, together with Neiker-Tecnalia (the ... tubers in air, by means of a novel system ... a pioneering experience in Spain, given that never before ...
... size of the Gulf oil spill, the possible risks ... fate of an endangered fish in the Colorado River ... Science Journalism Awards. The awards, administered by the ... their inception in 1945, go to professional journalists for ...
... MADISON, WI November 8, 2010 -- Conversion of sorghum ... fuel sources. Researchers at Iowa State University examined 12 varieties ... The experiment was designed to test the efficiency of double ... The author of the report, Ben Goff, found ...
Cached Biology News:Newco produces seed potatoes in the open air 2Newco produces seed potatoes in the open air 3Winners of 2010 AAAS Kavli Science Journalism Awards 2Winners of 2010 AAAS Kavli Science Journalism Awards 3Winners of 2010 AAAS Kavli Science Journalism Awards 4Winners of 2010 AAAS Kavli Science Journalism Awards 5Winners of 2010 AAAS Kavli Science Journalism Awards 6Winners of 2010 AAAS Kavli Science Journalism Awards 7Winners of 2010 AAAS Kavli Science Journalism Awards 8Growing sorghum for biofuel 2
Curcumin is an extract of turmeric root with antioxidant, anti-tumor promoter, and anti-inflammatory properties. Curcumin inhibits the induction of NOS in macrophages....
UGT1A6 (D-20)...
... is the smallest electronic pressure controller available ... Parker configured this unit specifically for the ... Used in carrier gas flow control, microfluidic ... and hydro-dynamic focusing, the OEM-EPC offers external ...
... Thrust Slide is designed for heavy duty ... limited and substantial side-loading is present. Standard ... millions of trouble-free cycles even in high ... or recirculating ball bearings , Optional corrosion ...
Biology Products: